methylprednisolone has been researched along with End Stage Liver Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, B; Casey, L; Cuthbert, J; Dasarathy, S; Holbein, MEB; Kroll-Desrosiers, A; McClain, CJ; McCullough, AJ; Min, HA; Mitchell, M; Nagy, LE; Radaeva, S; Szabo, G; Tornai, D | 1 |
| Shen, M; Tan, S; Tang, L; Wang, F; Xia, S; Xiao, L; Zhang, F; Zhang, Z; Zheng, S | 1 |
| Botea, A; Brown, LG; Buxhoeveden, M; Chaudhry, F; Eloy, JD; Greco, SJ; Gubenko, Y; Koneru, B; Liu, K; Mourad, Y; Ponzio, NM; Pyrsopoulos, N; Rameshwar, P; Schoenberg, C; Walker, ND; Wilson, DJ | 1 |
| Jain, V; Kathuria, R; Krishnani, N; Kumari, N; Poddar, U; Sarma, MS; Srivastava, A; Yachha, SK | 1 |
| Ahmadinejad, Z; Aminian, A; Ayoubi Yazdi, N; Azmoudeh-Ardalan, F; Davoudi, S; Eghtesad, B; Emami Meybodi, SA; Fakhar, N; Jafarian, A; Kasraianfard, A; Kazemeini, AR; Makarem, J; Mohagheghi, MA; Moini, M; Najafi, A; Nassiri-Toosi, M; Nejatisafa, AA; Rabbani, A; Rokni Yazdi, H; Saberi, H; Salimi, J; Sattarzadeh, R; Seifi, S; Shariat Moharari, R; Sohrabpour, AA; Tavakoli, H | 1 |
| He, YL; Li, J; Liu, HX; Meng, QH; Shi, SY; Wang, FS; Wang, JH; Xu, XS; Yao, QW; Yu, HW; Zhang, JY; Zhao, J; Zhao, JJ; Zhou, CB; Zhu, YK; Zou, ZS | 1 |
1 trial(s) available for methylprednisolone and End Stage Liver Disease
| Article | Year |
|---|---|
IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
Topics: Adrenal Cortex Hormones; Adult; End Stage Liver Disease; Female; Hepatitis, Alcoholic; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Methylprednisolone; Middle Aged; Pentoxifylline; Receptors, Interleukin-1; Severity of Illness Index; Zinc | 2022 |
5 other study(ies) available for methylprednisolone and End Stage Liver Disease
| Article | Year |
|---|---|
Yi-Qi-Jian-Pi formula modulates the PI3K/AKT signaling pathway to attenuate acute-on-chronic liver failure by suppressing hypoxic injury and apoptosis in vivo and in vitro.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; End Stage Liver Disease; Gene Expression Regulation; Hepatocytes; Liver; Male; Methylprednisolone; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley | 2021 |
Steroid-Mediated Decrease in Blood Mesenchymal Stem Cells in Liver Transplant could Impact Long-Term Recovery.
Topics: Case-Control Studies; Cell Count; Cell Movement; Chemokine CXCL12; End Stage Liver Disease; Gene Expression Regulation; Graft Rejection; Humans; Immunosuppressive Agents; Liver; Liver Transplantation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Methylprednisolone; Primary Cell Culture; Receptors, CXCR4; Recovery of Function; Signal Transduction | 2017 |
Autoimmune acute liver failure and seronegative autoimmune liver disease in children: Are they different from classical disease?
Topics: Adolescent; Alanine Transaminase; Ascites; Aspartate Aminotransferases; Autoantibodies; Autoimmune Diseases; Azathioprine; Bilirubin; Child; Child, Preschool; End Stage Liver Disease; Female; Glucocorticoids; Hepatic Encephalopathy; Humans; Immunosuppressive Agents; Infant; Jaundice; Liver Failure, Acute; Male; Massive Hepatic Necrosis; Methylprednisolone; Recurrence; Serum Albumin; Severity of Illness Index; Treatment Outcome | 2017 |
Establishing a liver transplantation program at Tehran University of Medical Sciences, Iran: a report of ten years of experience.
Topics: Academic Medical Centers; Adolescent; Adult; Child; Cohort Studies; End Stage Liver Disease; Female; Humans; Immunosuppressive Agents; Iran; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Program Development; Treatment Outcome; Young Adult | 2014 |
Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy.
Topics: Adult; Case-Control Studies; Dendritic Cells; End Stage Liver Disease; Female; Glucocorticoids; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Liver Failure, Acute; Male; Methylprednisolone; Middle Aged; Myeloid Cells | 2012 |